These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3290710

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Overview of the rationale for immunomodulating therapies in multiple sclerosis.
    Lisak RP.
    Neurology; 1988 Jul; 38(7 Suppl 2):5-8. PubMed ID: 3290714
    [Abstract] [Full Text] [Related]

  • 25. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G, Antonello RM, Zorzon M, Torre P, Zivadinov R, Moretti R, Bragadin LM, De Masi R, Nasuelli D.
    Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cell number requirements for lymphocyte stimulation in vitro: changes during the course of multiple sclerosis and the effects of immunosuppression.
    Knight SC, Harding B, Burman S, Mertin J.
    Clin Exp Immunol; 1981 Oct; 46(1):61-9. PubMed ID: 7039882
    [Abstract] [Full Text] [Related]

  • 28. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
    Kappos L.
    Schriftenr Neurol; 1990 Oct; 32():1-200. PubMed ID: 2200108
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Immunotherapy of multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials].
    Ozawa K, Saida T.
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1501-3. PubMed ID: 8752444
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Current studies of the effects of immunosuppressive agents on multiple sclerosis].
    Minderhoud JM.
    Ned Tijdschr Geneeskd; 1989 Jan 21; 133(3):99-100. PubMed ID: 2646546
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. New perspectives in the natural history of multiple sclerosis.
    Tremlett H, Zhao Y, Rieckmann P, Hutchinson M.
    Neurology; 2010 Jun 15; 74(24):2004-15. PubMed ID: 20548045
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F, Marteau R, Roullet E, de Saxcé H, Loridan M.
    Rev Neurol (Paris); 1984 Jun 15; 140(10):553-8. PubMed ID: 6438761
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Immunosuppressive treatment of multiple sclerosis. 4. Results of treatment with azathioprine and antilymphocyte globulin (author's transl)].
    Frick E, Angstwurm H, Blomer R, Strauss G.
    MMW Munch Med Wochenschr; 1977 Sep 02; 119(35):1111-4. PubMed ID: 408666
    [Abstract] [Full Text] [Related]

  • 40. [Study of 213 cases of multiple sclerosis treated with azathioprine from 1967- to 1982].
    Aimard G, Confavreux C, Ventre JJ, Guillot M, Devic M.
    Rev Neurol (Paris); 1983 Sep 02; 139(8-9):509-13. PubMed ID: 6648202
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.